CDSCO greenlights Azithromycin 1.2% periodontal gel

Azithromycin 1.2% periodontal gel received CDSCO approval in January 2026 as an adjunct to scaling and root planing in chronic periodontitis. Subgingival application once weekly for three weeks. Now commercially available in India to enhance localized antibiotic therapy and clinical outcomes.